benzamidoxime has been researched along with guanoxabenz in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bittner, F; Clement, B; Gruenewald, S; Hungeling, H; Kanzow, S; Kotthaus, J; Mendel, RR; Schwering, U; Wahl, B | 1 |
| Clement, B; Indorf, P; Kubitza, C; Kunze, T; Scheidig, AJ | 1 |
| Clement, B; Deters, S; Havemeyer, A; Mau, S | 1 |
3 other study(ies) available for benzamidoxime and guanoxabenz
| Article | Year |
|---|---|
The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
Topics: Animals; Benzamidines; Cattle; Cell Line; Chemistry, Pharmaceutical; Cloning, Molecular; Cytochrome-B(5) Reductase; Drug Design; Humans; Ligands; Models, Chemical; Molybdenum; Oxidoreductases; Prodrugs; Recombinant Proteins; Temperature | 2008 |
Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.
Topics: Biological Assay; Humans; Inactivation, Metabolic; Metabolic Clearance Rate; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Oximes; Substrate Specificity | 2020 |
Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
Topics: Animals; Benzamidines; Cytochrome P-450 Enzyme System; Cytochrome-B(5) Reductase; Cytochromes b5; Guanabenz; Heterocyclic Compounds; Humans; In Vitro Techniques; Kidney; Kinetics; Liver; Microsomes, Liver; Mitochondria; Oximes; Prodrugs; Swine | 2005 |